aTYR PHARMA INC: cashflow_financing

Value{"amount": 5451000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2022-01-01 – 2022-12-31
Statuscurrent
EntityaTYR PHARMA INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-23-007873 · Open the official SEC filing →
Retrieved: 2026-08-19T12:49:28.461302+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001339970/cashflow-financing/2022-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/cd60b3ef-84dd-4675-8293-e3ad4907dc89

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies